Ticker: KALV

Company: Carbylan Therapeutics, Inc.

Person: Nicole Sweeny, officer

Transaction date: Feb. 21, 2026

Reporting date: Feb. 24, 2026

Average share price: -8.50557113402062

Sold 7275.0 shares for 61878.03